Emily Jensen has joined the TriTiCon team as a consultant.
Emily Jensen holds a Ph.D. in Vascular Disease from Birmingham University in the UK. Emily started working in the pharmaceutical industry in 2013, as a Clinical Trial Manager at Ferring Pharmaceuticals in Copenhagen, Denmark. She held this role until late 2017, and she was responsible for the coordination and management of activities related to Phase 2 and Phase 3 international clinical trials in start-up, trial conduct and trial closure phases.
Emily has excellent communication abilities and a track record of enhancing effective collaboration between members of the team. Having worked in several different fields and international environments, she has a attained a broad range of transferable skills which provide a solid foundation for her current role as a member of TriTiCon.
